Every 10-Q that OneMedNet Corp Warrant (ONMDW) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow ONMDW and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ONMDW filings page.
OneMedNet Corporation, a healthcare software company focused on real-world data from medical imaging, reported continued operating losses and liquidity pressure for the quarter and six months ended June 30, 2026. Revenue was modest but growing, with quarterly revenue of $0.3 million, up from $0.2 million a year earlier, driven by higher data delivery volumes on its iRWD platform after decommissioning its legacy BEAM subscription product.
Despite this growth, the company posted a quarterly gross loss of $0.6 million, an operating loss of $2.3 million, and a six‑month net loss of $4.6 million. Cash and cash equivalents were only $0.4 million against total liabilities of $4.9 million and a stockholders’ deficit of $3.5 million, and management states that these conditions raise substantial doubt about its ability to continue as a going concern.
The company funded operations through related‑party equity subscriptions and a 2024 Standby Equity Purchase Agreement, issuing additional shares and expanding its share count to 59.3 million common shares outstanding as of August 11, 2026. It exited all Bitcoin holdings, recorded gains from warrant and SEPA derivative remeasurements, and in July 2026 entered a new $25.0 million SEPA with Yorkville. OneMedNet also discloses noncompliance with Nasdaq’s $1.00 minimum bid price requirement and ongoing material weaknesses in internal controls over financial reporting.
OneMedNet Corporation reported Q1 2026 revenue of $96,000 and a net loss of $2.5 million, reflecting a 30% revenue decline and wider losses versus Q1 2025. Cost of revenue of $0.5 million produced a negative gross margin, and operating expenses remained high at $2.2 million.
Cash and cash equivalents fell to $233,000 as of March 31, 2026, against $5.6 million of total liabilities and a stockholders’ deficit of $4.1 million. Management disclosed substantial doubt about the company’s ability to continue as a going concern and is relying on equity financing, including a Yorkville SEPA draw and related-party subscriptions.
The company holds a small Bitcoin position, realizes gains and losses from sales, and received an April 2026 Nasdaq notice for noncompliance with the $1.00 minimum bid price rule, with a grace period to regain compliance.
OneMedNet reported mixed results: operating revenue declined while non-operating items improved the bottom line. Total revenue was $155 thousand for the quarter (subscription $47k; web imaging $108k), down from $227k year-over-year, and gross margin was negative $(241)k. The company recorded net income of $2.98 million for the quarter and $1.08 million for the six months, driven largely by a $3.71 million gain on troubled debt restructurings, realized Bitcoin gains, and fair value adjustments.
Balance sheet and liquidity remain constrained: cash was $122k and Bitcoin fair value $1.598 million (15 units), total assets $2.337 million, and total liabilities fell to $6.177 million from $19.677 million due to debt-to-equity conversions and settlements. Stockholders' deficit improved to $(3.84) million. Management states the cash and Bitcoin balance are not adequate to fund operations for 12 months, raising substantial doubt about going concern and requiring additional financing.